Results 71 to 80 of about 4,080 (215)

A gyógyszer indukált állcsontnekrózis mikrobiológiája

, 2020
Napjainkban egyre gyakoribbak azon malignus és benignus kórképek, melyek során számos antireszorptív, vagy antiangiogén hatással bíró készítményt alkalmaznak, hogy csökkentsék a csontot érintő szövődményeket.
Maár, Nikolett
core  

Shared molecular framework and bidirectional effects of osteoporosis on periodontal disease and dental implant therapy in the elderly

Periodontology 2000, EarlyView.
Abstract Objectives This review synthesizes evidence regarding the prevalence, epidemiological associations, and mechanistic pathways between osteoporosis, periodontal disease, and dental implant therapy. Materials and Methods A literature review was conducted to identify studies focused on: osteoporosis, periodontal disease, and dental implants ...
Samin Sirous, Jaclyn C. Chalmers, Pin‐Ying Li, Yumna Subhani, Yvonne L. Hernandez‐Kapila   +4 more
wiley   +1 more source

Decoding host–microbial dynamics in peri‐implantitis: Ecosystem‐specific experimental models

Periodontology 2000, EarlyView.
Abstract Background Peri‐implantitis is an inflammatory disease arising within a unique host–microbial–biomaterial ecosystem. Unlike periodontitis, peri‐implant tissues lack a periodontal ligament and epithelial junction integrity and interface with metal oxides on titanium surfaces.
Georgios A. Kotsakis, Davi Araújo, Asaf Wilensky, Juliana Girón Bastidas, Stella Alimperti, Flavia Pirih   +5 more
wiley   +1 more source

Clinical and Radiological Evaluation of Oral and Maxillofacial Status in Patients Undergoing Antiresorptive Therapy and Its Relationship with MRONJ

Biomedicines
Background/Objectives: Patients undergoing antiresorptive therapy were evaluated, focusing on clinical and radiological features and their relationship with medication-related osteonecrosis of the jaw (MRONJ).
Marcela Wiltgen Jeffman, Valesca Sander Koth, Fernanda Gonçalves Salum, Maria Ivete Rockenbach, Aline Cantarelli Morosolli, Karen Cherubini   +5 more
doaj   +1 more source

Antiresorptive therapy influence on peri‐implant diseases: Clinical implications and osteoimmunological perspectives

Periodontology 2000, EarlyView.
Abstract Background/Aim Antiresorptive therapy represents a cornerstone in the management of osteoporosis and cancer‐related bone disease through suppression of osteoclast‐mediated bone resorption. As implant therapy becomes more common in aging populations, clinicians increasingly encounter patients receiving these medications, thus making their ...
Emilio A. Cafferata, Frank Schwarz, Reinhard Gruber   +2 more
wiley   +1 more source

Management of severe bone loss in patients at risk of medication‐related osteonecrosis of the jaw with microsurgery and guided bone regeneration: A case study

Clinical Advances in Periodontics, Volume 16, Issue 3, Page 538-547, September 2026.
Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a challenging complication associated with antiresorptive medications. Its exact pathophysiology remains unclear, but dental extractions and infections are known triggers, complicating prevention, and treatment.
Pedro Franco Ferreira, José Maurício Paradella de Camargo, Lara Maria Alencar Ramos Innocentini, Ana Carolina Fragoso Motta   +3 more
wiley   +1 more source

PRZYPADEK POLEKOWEJ MARTWICY ŻUCHWY (MRONJ)

Wiadomości Lekarskie
Wstęp: Polekowa osteonekroza kości jest poważnym powikłaniem związanym głównie z długotrwałym stosowaniem leków antyresorbcyjnych takich, jak bifosfoniany i denosunab. Terapia bisfosfonianami jest częstym leczeniem z wyboru osteoporozy. Działanie tych leków polega na hamowaniu procesu rozkładu kości.
Vasyl Behun, Julia Maślanka, Daria Wziątek-Kuczmik   +2 more
openaire   +1 more source

Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review

, 2022
Antiresorptive agents such as bisphosphonates (BP) and denosumab are commonly prescribed for the management of primary bone malignancy, bone metastasis, osteoporosis, Paget disease, or other bone disorders.
Panagiotis Gouveris, Danny Hadaya, Dionysia Zouki, Ioannis Gkouveris, Akrivoula Soundia, Sotirios Tetradis   +5 more
core   +1 more source

Early identification and differential diagnosis of non-exposed medication-related osteonecrosis of the jaw

Kouqiang hemian waike zazhi
The diagnosis of medication-related osteonecrosis of the jaw (MRONJ) currently lacks a globally unified "gold standard", with discrepancies existing among the consensus statements or guidelines of various academic societies.
ZHANG Xueming, CAO Shaokang, WANG Xinyi, KANG Feiwu   +3 more
doaj   +1 more source

What Is MRONJ? [PDF]

The Journal of the American Dental Association, 2021
openaire   +2 more sources